Breaking News Instant updates and real-time market news.

XENT

Intersect ENT

$23.33

-1.51 (-6.08%)

07:14
01/13/20
01/13
07:14
01/13/20
07:14

Intersect ENT sees FY20 revenue $115M-$119M, consensus $119.69M

Intersect ENT said, "On a quarterly basis, we expect revenue growth to build throughout the year."

  • 13

    Jan

XENT Intersect ENT
$23.33

-1.51 (-6.08%)

09/30/19
BOFA
09/30/19
DOWNGRADE
Target $67
BOFA
Underperform
Glaukos downgraded to Underperform from Buy at BofA/Merrill
BofA/Merrill analyst Bob Hopkins double downgraded Glaukos (GKOS) to Underperform from Buy and lowered his price target for the shares to $67 from $75. The analyst remains bullish on the company's long term prospects and sees no issues with its Q3 and Q4 results, but he prefers other names in the space given the potential distraction associated with the integration of Avedro. Hopkins also lowered his price target for ShockWave Medical (SWAV) to $40 from $64 and for Intersect ENT (XENT) to $22 from $39.
10/07/19
WBLR
10/07/19
NO CHANGE
WBLR
Outperform
Drug-coated sinus balloon not core to Intersect ENT thesis, says William Blair
After Intersect ENT announced that its clinical study of the safety and efficacy of the company's drug-coated sinus balloon failed to meet its primary endpoint, William Blair analyst Brian Weinstein called the news "a disappointing and frustrating development," but also said he never viewed this product as core to to his Outperform thesis for the stock. His focus for Intersect is much more on execution and returning to growth by selling the PROPEL family of products, Weinstein tells investors. Noting that he will try to speak with management later today, Weinstein said that for now he thinks investors should assume this product does not contribute in any way to revenues. However, he still thinks PROPEL products and SINUVA remain underpenetrated opportunities.
10/07/19
PIPR
10/07/19
NO CHANGE
Target $17
PIPR
Overweight
Intersect ENT trial miss 'another incremental negative,' says Piper Jaffray
Intersect ENT's announcement this morning that the study of its drug-coated sinus balloon missed the primary endpoint at 30 days is "another incremental negative" for the company, Piper Jaffray analyst Matt O'Brien tells investors in a research note. While the growth driver was likely several years out, the news is another incremental negative for shares that have performed poorly in 2019, writes the analyst. O'Brien, while acknowledging "that this is not the end of the world," and that a second trial is possible, is unsure of Intersect ENT's next steps at this point. He sees a largely balanced risk/reward profile on the shares and keeps a Neutral rating on Intersect ENT with a $17 price target.
11/01/19
PIPR
11/01/19
NO CHANGE
PIPR
Neutral
Piper calls Intersect ENT Q3 a 'nice first step,' awaits more execution evidence
Piper Jaffray analyst Matt O'Brien called Intersect ENT's third quarter results "a positive first step in the right direction," but he needs to see more than one quarter of stable execution before becoming more constructive on the stock. He notes that Q3 revenue that was largely in-line with consensus expectations and said his "big takeaway" from the company's report was the healthy implied demand for PROPEL. O'Brien raised his price target on Intersect ENT shares to $21 from $17 but keeps a Neutral rating on the stock.

TODAY'S FREE FLY STORIES

JNJ

Johnson & Johnson

$149.03

0.78 (0.53%)

13:17
01/17/20
01/17
13:17
01/17/20
13:17
Periodicals
Judge cuts J&J punishment in Risperdal case to $6.8M from $8B, Bloomberg reports »

On October 8, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Mar

  • 17

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
01/17/20
01/17
13:17
01/17/20
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
01/17/20
01/17
13:16
01/17/20
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKR

Baker Hughes

$23.56

0.06 (0.26%)

13:04
01/17/20
01/17
13:04
01/17/20
13:04
Hot Stocks
Baker Hughes reports U.S. rig count up 15 to 796 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Mar

MDR

McDermott

$0.73

0.0119 (1.66%)

13:02
01/17/20
01/17
13:02
01/17/20
13:02
Hot Stocks
McDermott announces start of commercial operation of Freeport LNG Train 2 »

McDermott International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$240.69

0.17 (0.07%)

13:02
01/17/20
01/17
13:02
01/17/20
13:02
Recommendations
Amgen analyst commentary  »

Amgen raised prices today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

BKR

Baker Hughes

$23.57

0.07 (0.30%)

13:01
01/17/20
01/17
13:01
01/17/20
13:01
Hot Stocks
Breaking Hot Stocks news story on Baker Hughes »

Baker Hughes reports U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Mar

SNCA

Seneca Biopharma

$3.09

1.84 (147.20%)

12:59
01/17/20
01/17
12:59
01/17/20
12:59
Hot Stocks
Seneca Biopharma surges after saying talks starting with 'interested parties' »

Shares of micro-cap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUPH

Aurinia Pharmaceuticals

$20.02

0.19 (0.96%)

12:45
01/17/20
01/17
12:45
01/17/20
12:45
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
01/17/20
01/17
12:45
01/17/20
12:45
General news
Breaking General news story  »

Week of 1/17 Baker-Hughes…

12:45
01/17/20
01/17
12:45
01/17/20
12:45
General news
Breaking General news story  »

Week of 1/17 Baker-Hughes…

DLAKY

Lufthansa

$0.00

(0.00%)

12:41
01/17/20
01/17
12:41
01/17/20
12:41
Periodicals
Lufthansa extends Tehran flight halt until March 28, Reuters reports »

Lufthansa said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$139.71

-0.32 (-0.23%)

12:36
01/17/20
01/17
12:36
01/17/20
12:36
Hot Stocks
Toyota provides outline of production alignment through 2022 »

To "improve the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$139.71

-0.32 (-0.23%)

12:33
01/17/20
01/17
12:33
01/17/20
12:33
Hot Stocks
Toyota Indiana completes $1.3B modernization, adds 550 new jobs »

Toyota Indiana invested…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:30
01/17/20
01/17
12:30
01/17/20
12:30
General news
Treasury Dealer Agenda: the dealer meeting will be held on January 30, 31 »

Treasury Dealer Agenda:…

12:30
01/17/20
01/17
12:30
01/17/20
12:30
General news
Breaking General news story  »

Federal Reserve Board of…

12:30
01/17/20
01/17
12:30
01/17/20
12:30
General news
Breaking General news story  »

Federal Reserve Board of…

AXTA

Axalta Coating

$30.30

0.225 (0.75%)

12:25
01/17/20
01/17
12:25
01/17/20
12:25
Options
Axalta Coating call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

12:25
01/17/20
01/17
12:25
01/17/20
12:25
Conference/Events
Federal Reserve Board of Governors Vice Chairman speaks at a meeting »

Randal Quarles, Vice…

MSFT

Microsoft

$165.58

-0.66 (-0.40%)

, WORK

Slack Technologies

$22.68

-0.28 (-1.22%)

12:23
01/17/20
01/17
12:23
01/17/20
12:23
Periodicals
Microsoft to launch global ad campaign for Teams, CNBC reports »

Microsoft (MSFT) will…

MSFT

Microsoft

$165.58

-0.66 (-0.40%)

WORK

Slack Technologies

$22.68

-0.28 (-1.22%)

IPG

Interpublic Group

$23.96

0.22 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 12

    Feb

  • 25

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
01/17/20
01/17
12:17
01/17/20
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
01/17/20
01/17
12:16
01/17/20
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$144.95

-0.15 (-0.10%)

12:07
01/17/20
01/17
12:07
01/17/20
12:07
Periodicals
Disney dropping 'Fox' name from 21st Century Fox assets, Variety reports »

Disney is dropping the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

TWOU

2U

$22.88

1.09 (5.00%)

12:06
01/17/20
01/17
12:06
01/17/20
12:06
Periodicals
2U mulls potential sale after activist pressure, Bloomberg reports »

2U has tapped advisers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$315.89

0.56 (0.18%)

12:04
01/17/20
01/17
12:04
01/17/20
12:04
Hot Stocks
Apple announces overall deal with Julia Louis-Dreyfus for TV+ »

Apple has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.